Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Transplantation. 2019 Feb;103(2):307–313. doi: 10.1097/TP.0000000000002455

Table 2:

Effect of MSC Administration in Ischemically Damaged Human Kidneys

Pretreatment Posttreatment* (% Change)

MSC Infusion MAP
(mmHg)
Flow
(cc/min)
O2 Consumption
(cc/min/g)
MAP
(mmHg)
Flow
(cc/min)
O2 Consumption
(cc/min/g)

.25 × 108 27.7 113 0.15 −7.8 23.6 42.3
.5 × 108 27.7 153 0.11 −6.4 25.0 38.9
.75 × 108 34.0 179 0.09 − 4.1 3.24 55.0
1.0 × 108 34.0 150 0.11 −14.6 28.6 21.4
2.0 × 108 27.7 95 0.15 34.1 21.8 −66.7

N=2 for each dose of MSC

MAP = Mean Arterial Pressure

*

at 24 hours of warm perfusion

+Oxygenconsumption={(PaO2artery)(PaO2vein)XFlowRate(literperminute)}Weight(g)